Diabetes, Vol 38, Issue 2 182-187, Copyright © 1989 by American Diabetes Association

ARTICLES

Mechanisms of insulin-induced insulin-receptor downregulation. Decrease of receptor biosynthesis and mRNA levels

Y Okabayashi, BA Maddux, AR McDonald, CD Logsdon, JA Williams and ID Goldfine
Cell Biology Laboratory, Mount Zion Hospital, San Francisco, California 94120.

The influence of insulin on the downregulation of its receptor was studied in AR42J cultured pancreatic acinar cells, a cell line that has been demonstrated to be metabolically responsive to insulin. Downregulation induced by insulin was time and dose dependent. After a 20-h incubation with 1 microM insulin, Scatchard analysis revealed approximately 80% loss of insulin receptors. Studies of receptor half-life indicated that treatment with insulin accelerated the degradation of both the alpha- and beta-subunits of the insulin receptor by 30-60%. In addition, biosynthetic-labeling studies indicated that insulin inhibited the biosynthesis of the insulin-receptor precursor by greater than 30%. This decreased biosynthesis of the precursor was associated with decreased production of mature receptor subunits. Poly(A)+ RNA was extracted from control cells and cells treated for 24 h with 100 nM insulin. Slot blots and Northern transfers revealed that insulin induced an approximately 50% decrease in insulin-receptor mRNA levels. Therefore, these studies indicate that insulin may diminish the concentration of its receptors in target cells by at least two mechanisms: acceleration of receptor degradation and inhibition of receptor biosynthesis at the level of mRNA.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				A.M. J. Shapiro, C. Ricordi, B. J. Hering, H. Auchincloss, R. Lindblad, R. P. Robertson, A. Secchi, M. D. Brendel, T. Berney, D. C. Brennan, et al. International Trial of the Edmonton Protocol for Islet Transplantation. N. Engl. J. Med., September 28, 2006; 355(13): 1318 - 1330. [Abstract] [Full Text] [PDF]

				X. Huang, A. Vaag, M. Hansson, and L. Groop Down-Regulation of Insulin Receptor Substrates (IRS)-1 and IRS-2 and Src Homologous and Collagen-Like Protein Shc Gene Expression by Insulin in Skeletal Muscle Is Not Associated with Insulin Resistance or Type 2 Diabetes J. Clin. Endocrinol. Metab., January 1, 2002; 87(1): 255 - 259. [Abstract] [Full Text] [PDF]

				D. Spampinato, G. Pandini, A. Iuppa, V. Trischitta, R. Vigneri, and L. Frittitta Insulin/Insulin-Like Growth Factor I Hybrid Receptors Overexpression Is Not an Early Defect in Insulin-Resistant Subjects J. Clin. Endocrinol. Metab., November 1, 2000; 85(11): 4219 - 4223. [Abstract] [Full Text]

				M. Bursztyn, J. Mekler, E. Peleg, and J. Bernheim Subpressor Dose of L-NAME Unmasks Hypertensive Effect of Chronic Hyperinsulinemia Hypertension, November 1, 2000; 36(5): 872 - 877. [Abstract] [Full Text] [PDF]

				S. Bortoli, M. Amessou, M. Collinet, B. Desbuquois, and S. Lopez Vanadate, But Not Insulin, Inhibits Insulin Receptor Gene Expression in Rat Hepatoma Cells Endocrinology, November 1, 1997; 138(11): 4821 - 4829. [Abstract] [Full Text] [PDF]